Tunisia Tackles Medicine Shortages with Digital Reforms

Patients across Tunisia will soon have reliable access to medicines year-round, thanks to a comprehensive reform plan approved this week by Prime Minister Sara Zaafrani Zenzri's cabinet.

The government is immediately releasing emergency funds to the Central Pharmacy of Tunisia to restore steady medicine supplies nationwide. For too long, hospitals and pharmacies have struggled with unpredictable shortages that left patients searching for essential medications.

But this is more than a quick fix. Tunisia is building a strategic stockpile of essential and specialized drugs to prevent future crises. The country is also fast-tracking approvals for new medicines, cutting red tape that previously slowed access to treatments.

The digital transformation stands out as particularly ambitious. Tunisia will digitize its entire pharmaceutical supply chain, allowing real-time tracking from manufacturers to patients. This means better stock management, fewer shortages, and greater transparency about where medicines go and why.

Health Minister Mustapha Ferjani and Social Affairs Minister Issam Lahmar presented detailed assessments showing progress since earlier recommendations in September 2024. Their reports revealed specific gaps in the current system and clear pathways forward.

The government is also betting big on local production. By encouraging generic medicine manufacturing inside Tunisia, the country can reduce expensive imports and create jobs. Prime Minister Zenzri emphasized positioning Tunisia as a pharmaceutical hub for African and global markets, including developing a national roadmap for vaccine production.

The Ripple Effect

These reforms extend far beyond medicine cabinets. Strengthening pharmaceutical manufacturing means new investment opportunities and export potential for Tunisia's economy. Local production creates skilled jobs in science and manufacturing while reducing the country's vulnerability to global supply chain disruptions.

The digitalization effort will improve governance across the entire healthcare system, making it easier to spot problems before they become crises. Enhanced monitoring and inspection mechanisms mean greater accountability and less waste.

Most importantly, equitable access means families in rural areas will have the same medicine availability as those in major cities. No parent should have to travel hours or pay inflated prices for their child's medication.

Tunisia is turning a healthcare challenge into an opportunity for economic growth and regional leadership in pharmaceutical innovation.